DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Vanoxerine
Vanoxerine
Experimental Dopamine Reuptake Inhibitors in Parkinson’S Disease: a Review of the Evidence
Upregulation of Peroxisome Proliferator-Activated Receptor-Α And
Characterization of Mice with Altered Dopamine Transporter and Vesicular Monoamine Transporter 2 Levels
EUROPEAN COMMISSION Brussels, 11.7.2011 SEC(2011)
Compositions and Methods for Selective Delivery of Oligonucleotide Molecules to Specific Neuron Types
S1 Figa
Monoamine Reuptake Inhibitors in Parkinson's Disease
Product Data Sheet
Cocaine Or Selective Block of Dopamine Transporters Influences Multisecond Oscillations in Firing Rate in the Globus Pallidus David N
Review Article Monoamine Reuptake Inhibitors in Parkinson's Disease
Lääkealan Turvallisuus- Ja Kehittämiskeskuksen Päätös
Treatment of Problem Cocaine Use a Review of the Literature the of Review a Literature
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
Discovery of Vanoxerine Dihydrochloride As a CDK2 / 4 / 6 Triple-Inhibitor for the Treatment of Human Hepatocellular Carcinoma
New Horizons for Therapeutics in Drug and Alcohol Abuse
Dopamine Transporter DAT; SLC6A3
Catecholamines: Knowledge and Understanding in the 1960S, Now, and in the Future
BBC Program 2011
Top View
Modulation of Cocaine-Like Behavioural Activity By
(12) United States Patent (10) Patent No.: US 7.964,728 B2 Stoit Et Al
The Effect of Monoamines Reuptake Inhibitors on Aerobic Exercise
Datasheet Inhibitors / Agonists / Screening Libraries a DRUG SCREENING EXPERT
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Human Butyrylcholinesterase Mutants for Cocaine Detoxification
Pharmacology and Toxicology
EMCDDA RISK ASSESSMENTS Report on the Risk Assessment of BZP in the Framework of the Council Decision on New Psychoactive Substances
Pharmaabkommen A1 E
Synthesis of Two Testosterone Derivatives and Their Theoretical Evaluation As Serotonin Reuptake Transporter Inhibitors
Review Drug Addiction. Part Iii. Pharmacotherapy of Addiction
A Multicenter, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Long-Acting Injectable Formulation Of
Customs Tariff - Schedule Xxi - 1
An Investigation of Motivational Dysfunctions in a Rat Model Of
A Brief Essay on the Use of Antidepressants for Cocaine Dependence
Kokain Bağımlılığında Vanoxerine Consta Kullanımı: Bir Olgu Sunumu
Studies on the Role of Cannabinoids on Dopamine Transporter Function: An
Qualifying Therapeutic Discovery Project Grants
Evaluation of Agonist Pharmacotherapy for Cocaine Dependence: Effects of Continuous D-Amphetamine Treatment on Cocaine Self-Administration in Rats
US 2002/0019421 A1 Biberman (43) Pub
Joseph H. Porter · Adam J. Prus Editors the Behavioral Neuroscience of Drug Discrimination Current Topics in Behavioral Neurosciences
Lmis of the Drugs from GE-HTS Project
Rank Cmap Name 1 Trichostatin a 2 Piribedil 3 Omeprazole 4 MS-275 5 Penbutolol 6 Calcium Folinate 7 Phthalylsulfathiazole 8 Clop
Harmonized Tariff Schedule of the United States (2006) (Rev
WO 2012/170676 Al 13 December 2012 (13.12.2012) P O P C T
Nida Protocol
Medication Development for the Treatment of Cocaine Addiction – Progress at Preclinical and Clinical Levels
Lääkeluettelon Aineet, Liite 1
Clinical Utility of Datscan™ (123I-Ioflupane Injection) in the Diagnosis of Parkinsonian Syndromes
Discovery of Vanoxerine Dihydrochloride As a CDK2/4/6 Triple-Inhibitor for the Treatment of Human Hepatocellular Carcinoma
Veyres N, Hamadjida A, Huot P. Predictive Value of Parkinsonian Primates in Pharmacological Studies, a Comparison Between the Macaque, Marmoset and Squirrel Monkey
(12) Patent Application Publication (10) Pub. No.: US 2006/0270742 A1 Staunton Et Al
Copyrighted Material
Sex Differences in the Dopaminergic Regulation of Courtship, but Not Pairing Behaviors in Zebra Finches